Intervention

Kesimpta

ClinicalTrials.gov intervention label

Clinical trials3

Recruiting1

Common conditions4

Lead sponsors shown1

Clinical trials

3 shown

Kesimpta (Ofatumumab) Pregnancy RegistryNCT05634967 · 2023-01-05

A Survey to Evaluate Early Experience From Patient and Care Partner on Injection and Device for KESIMPTA® Indicated for Multiple SclerosisNCT05334472 · 2021-11-24

Special Drug-use Surveillance for Kesimpta for s.c. Injection 20 mg PenNCT04940065 · 2021-06-30

Common conditions

Multiple Sclerosis2 Active Secondary Progressive Multiple Sclerosis1 Pregnancy1 Relapsing-remitting Multiple Sclerosis1

Leading sponsors

Novartis Pharmaceuticals3

Trial status mix

COMPLETED2

RECRUITING1

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.